Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
Apr
3
2017
American Industrial Hygiene Association Publishes Nanomaterial Stewardship Guidance Bergeson & Campbell, P.C.
Jan
30
2019
American Lung Association Finds States, Federal Government Failed to Act to Reduce Tobacco Use Keller and Heckman LLP
Oct
20
2017
American Process and Byogy Renewables Launch Phase 1 Of DOE-Funded Biofuels And Bioproducts Project Bergeson & Campbell, P.C.
Jul
1
2015
American Simmental Assoc. v. Leachman Cattle of Colorado: Stay of Pending Reissue Application to Avoid Inconsistencies with Post Grant Review PGR2015-00005 Faegre Drinker
Jun
30
2015
American Simmental Association v. Leachman Cattle of Colorado, LLC: Decision on Institution of Post-Grant Review Faegre Drinker
Jan
14
2019
American Telemedicine Association Letter Offers Recommendations on DEA Special Registration for Telemedicine Prescribing of Controlled Substances Foley & Lardner LLP
Aug
26
2015
AmerisourceBergen Guest Post: Solutions to Overcome Reimbursement Challenges in Personalized Medicine Foley & Lardner LLP
Aug
27
2015
Amgen And Apotex Do The Biosimilar Patent Dance Foley & Lardner LLP
May
17
2016
Amgen And Sandoz Do Biosimilar Patent Dance Over Neulasta Foley & Lardner LLP
Sep
25
2015
Amgen At It Again – Sues Hospira For Not Wanting To Dance Over Biosimilar Michael Best & Friedrich LLP
Apr
7
2016
Amgen Hedges Its Bets With Cross-Petition For Certiorari Of Biosimilar Decision Foley & Lardner LLP
Aug
28
2015
Amgen Inc., et al. v. Sandoz, Inc.: Shall Means Shall . . . Unless It Doesn’t McDermott Will & Emery
Mar
3
2016
Amgen Launches Enbrel Biosimilar Patent Litigation Foley & Lardner LLP
Jan
9
2018
Amgen Moves to Dismiss Genentech’s Misrepresentation Claim Morgan, Lewis & Bockius LLP
Aug
17
2015
Amgen v. Apotex – what is the outcome when biosimilar applicants actually dance? Sterne, Kessler, Goldstein & Fox P.L.L.C.
Apr
27
2017
Amgen v. Sandoz: The Supreme Court’s First Tussle with the BPCIA Mintz
Feb
14
2021
Amgen v. Sanofi – How Wands Factors make Biotech Claims “Magically” Disappear Schwegman, Lundberg & Woessner, P.A.
Nov
11
2014
Amgen/Sandoz Disputes Will Clarify BPCIA (Biologics Price Competition and Innovation Act) Issues Sheppard, Mullin, Richter & Hampton LLP
Feb
21
2018
Amicus Briefs Filed in Support of Deeming Rule Appeal by Washington Legal Foundation, NJOY, CASAA, the State of Iowa and Clive Bates, et al. Keller and Heckman LLP
Apr
23
2015
Amicus Briefs On Biosimilar Patent Litigation Foley & Lardner LLP
Nov
15
2019
Amid Ongoing Trade Talks, U.S. and China Remove Import Restrictions on Poultry Products Keller and Heckman LLP
Sep
4
2019
Amidst Regulatory Uncertainty, Cell-Based Meat Startups Form Coalition Keller and Heckman LLP
Jul
22
2021
Amidst Uncertainty Surrounding the Scope of BIPA Liability, Hyatt Settles Employee Biometric Data Class Claims for $1.5 Million Hunton Andrews Kurth
Jul
28
2015
Amneal Pharm v. Endo Pharmaceuticals: Final Written Decision Finding Claim Limitation Not Inherently Disclosed IPR2014-00360 Faegre Drinker
Sep
30
2014
Amneal Pharmaceuticals v. Endo Pharmaceuticals, IPR2014-00360: Denying Request for Rehearing of Denial of Institution Faegre Drinker
Aug
2
2014
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc., Denying Institution IPR2014-00361 Faegre Drinker
Jul
2
2014
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc., Order Regarding Time Bar For Filing IPR IRP2014-00360 Faegre Drinker
Apr
21
2016
Amneal's IPR Challenge Of Jazz Xyrem + Valproate Patent Foley & Lardner LLP
Jan
14
2022
Amniotic Fluid Injections Are at the Center of the Federal Government’s New Enforcement Effort Oberheiden P.C.
Jan
9
2019
Amongst FDA SOI Conversation, Ninth Circuit Agrees Consumers Are Not Misled by Plant-Based Milks Keller and Heckman LLP
Jul
27
2020
AMS Proposes to Add “Sugarcane (Insect Resistant)” to the List of Bioengineered Foods Subject to Disclosure Under the National Bioengineered Food Disclosure Standard Keller and Heckman LLP
Apr
23
2024
AMS Publishes RFI on Electronic and Digital Link Disclosures Under the National Bioengineered Food Disclosure Standard Bergeson & Campbell, P.C.
Apr
4
2024
AMS Requests Information to Update List of Bioengineered Foods Bergeson & Campbell, P.C.
Mar
8
2018
An analysis of the DCMS Select Committee Report: ‘Combatting doping in sport’ Part 2 – “British Cycling and Team Sky” Squire Patton Boggs (US) LLP
Mar
7
2018
An analysis of the DCMS Select Committee Report: ‘Combatting doping in sport’ – Part 1 “Knowledge and prevalence of doping in world athletics” Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins